URL path: Index page // Endothelial Protein C Receptor (EPCR), Haplotype H1 (G4678C)

Endothelial Protein C Receptor (EPCR), Haplotype H1 (G4678C)

Molecular screening for the H1 haplotype of the endothelial protein C receptor (EPCR) gene is performed to assess the risk of thrombosis in asymptomatic patients with a family history or in patients who have already experienced a thromboembolic episode.

The endothelial protein C receptor (EPCR), also known as the activated protein C receptor (APC receptor), is a protein encoded by the PROCR gene. The protein encoded by this gene is a receptor for protein C that enhances its activation, plays a key role in regulating endothelial cell coagulation, inflammation and integrity. EPCR is a transmembrane glycoprotein, expressed primarily in endothelial cells, but also in a variety of other cells, including neutrophils. EPCR is also found as a plasma soluble form (sEPCR) where it binds activated protein C (APC) in competition with its cellular binding. Elevated levels of sEPCR have been associated with polymorphisms in the PROCR gene encoding the EPCR.

There are four haplotypes designated by corresponding polymorphisms: H1-H4. H3 haplotype has been associated with elevated plasma levels of sEPCR and has been proposed as a risk factor for venous thrombosis. In contrast to H3 haplotype, H1 haplotype has been associated with increased plasma APC concentration and a protective effect against venous thrombosis. Mutations in the PROCR gene have been associated with venous thromboembolism and myocardial infarction, as well as with delayed fetal loss during pregnancy. People with the H3 haplotype have a 1.8-fold increased risk of thrombosis. Those with the H1 haplotype in homozygosity have higher APC levels and therefore a reduced risk of venous thrombosis. Specifically, homozygotes (C / C) have a reduced risk of thrombosis by 0.61 times.

Thrombophilia is an acquired or congenital disorder associated with thrombosis. The clinical appearance of an underlying thrombophilia mainly involves venous thromboembolism, which is manifested as deep vein thrombosis, pulmonary embolism, or superficial vein thrombosis. Other events associated with thrombophilia include prolonged (recurrent) miscarriages and complications of pregnancy such as severe preeclampsia, placental abruption, and fetal endometrial death. The demographic and environmental characteristics that contribute to the risk of venous thromboembolism in people predisposed to thrombophilia include: old age, gender (more commonly in men), obesity, surgery, trauma, hospitalization, etc. malignant neoplasms, prolonged immobility (such as long plane trips), use of certain medications (such as contraceptives, estrogens, tamoxifen and raloxifene) and certain drugs used to treat hypoglycemia equality.

 

 

Important Note

Laboratory test results are the most important parameter for the diagnosis and monitoring of all pathological conditions. 70%-80% of diagnostic decisions are based on laboratory tests. Correct interpretation of laboratory results allows a doctor to distinguish "healthy" from "diseased".

Laboratory test results should not be interpreted from the numerical result of a single analysis. Test results should be interpreted in relation to each individual case and family history, clinical findings and the results of other laboratory tests and information. Your personal physician should explain the importance of your test results.

At Diagnostiki Athinon we answer any questions you may have about the test you perform in our laboratory and we contact your doctor to get the best possible medical care.

 

The test is not available for purchase online
Additional information
Share it